Difference between revisions of "Ceftazidime"

(Created page with "==General== *Type: *Dosage Forms: *Common Trade Names: ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Pregnancy: *Lactation: *Renal Dosing **Adult **Pedia...")
 
Line 31: Line 31:
 
*Excretion:  
 
*Excretion:  
 
*Mechanism of Action:
 
*Mechanism of Action:
 +
 +
==[[Antibiotic Sensitivities]]<ref>Sanford Guide to Antimicrobial Therapy 2014</ref>==
 +
{| class="wikitable"
 +
| align="center" style="background:#f0f0f0;"|'''Group'''
 +
| align="center" style="background:#f0f0f0;"|'''Organism'''
 +
| align="center" style="background:#f0f0f0;"|'''Sensitivity'''
 +
|-
 +
| Gram Positive||[[Strep. Group A, B, C, G]]||'''S'''
 +
|-
 +
| ||[[Strep. Pneumoniae]]||'''S'''
 +
|-
 +
| ||[[Viridans strep]]||I
 +
|-
 +
| ||Strep. anginosus gp||X1
 +
|-
 +
| ||[[Enterococcus faecalis]]||R
 +
|-
 +
| ||[[Enterococcus faecium]]||X1
 +
|-
 +
| ||[[MSSA]]||I
 +
|-
 +
| ||[[MRSA]]||R
 +
|-
 +
| ||[[CA-MRSA]]||R
 +
|-
 +
| ||[[Staph. Epidermidis]]||I
 +
|-
 +
| ||[[C. jeikeium]]||R
 +
|-
 +
| ||[[L. monocytogenes]]||R
 +
|-
 +
| Gram Negatives||[[N. gonorrhoeae]]||I
 +
|-
 +
| ||[[N. meningitidis]]||I
 +
|-
 +
| ||[[Moraxella catarrhalis]]||'''S'''
 +
|-
 +
| ||[[H. influenzae]]||'''S'''
 +
|-
 +
| ||[[E. coli]]||'''S'''
 +
|-
 +
| ||[[Klebsiella]] sp||'''S'''
 +
|-
 +
| ||E. coli/Klebsiella ESBL+||R
 +
|-
 +
| ||E coli/Klebsiella KPC+||R
 +
|-
 +
| ||[[Enterobacter]] sp, AmpC neg||'''S'''
 +
|-
 +
| ||[[Enterobacter]] sp, AmpC pos||R
 +
|-
 +
| ||[[Serratia]] sp||'''S'''
 +
|-
 +
| ||Serratia marcescens||X1
 +
|-
 +
| ||[[Salmonella]] sp||'''S'''
 +
|-
 +
| ||[[Shigella]] sp||'''S'''
 +
|-
 +
| ||[[Proteus mirabilis]]||'''S'''
 +
|-
 +
| ||[[Proteus vulgaris]]||'''S'''
 +
|-
 +
| ||[[Providencia sp.]]||'''S'''
 +
|-
 +
| ||[[Morganella sp.]]||'''S'''
 +
|-
 +
| ||[[Citrobacter freundii]]||R
 +
|-
 +
| ||[[Citrobacter diversus]]||'''S'''
 +
|-
 +
| ||[[Citrobacter sp.]]||'''S'''
 +
|-
 +
| ||[[Aeromonas sp]]||'''S'''
 +
|-
 +
| ||[[Acinetobacter sp.]]||I
 +
|-
 +
| ||[[Pseudomonas aeruginosa]]||'''S'''
 +
|-
 +
| ||[[Burkholderia cepacia]]||'''S'''
 +
|-
 +
| ||[[Stenotrophomonas maltophilia]]||I
 +
|-
 +
| ||[[Yersinia enterocolitica]]||I
 +
|-
 +
| ||[[Francisella tularensis]]||X1
 +
|-
 +
| ||[[Brucella sp.]]||X1
 +
|-
 +
| ||[[Legionella sp.]]||R
 +
|-
 +
| ||[[Pasteurella multocida]]||X1
 +
|-
 +
| ||[[Haemophilus ducreyi]]||'''S'''
 +
|-
 +
| ||[[Vibrio vulnificus]]||X1
 +
|-
 +
| Misc||[[Chlamydophila sp]]||X1
 +
|-
 +
| ||[[Mycoplasm pneumoniae]]||X1
 +
|-
 +
| ||[[Rickettsia sp]]||X1
 +
|-
 +
| ||[[Mycobacterium avium]]||X1
 +
|-
 +
| Anaerobes||[[Actinomyces]]||X1
 +
|-
 +
| ||[[Bacteroides fragilis]]||R
 +
|-
 +
| ||[[Prevotella melaninogenica]]||'''S'''
 +
|-
 +
| ||[[Clostridium difficile]]||X1
 +
|-
 +
| ||[[Clostridium (not difficile)]]||'''S'''
 +
|-
 +
| ||[[Fusobacterium necrophorum]]||X1
 +
|-
 +
| ||[[Peptostreptococcus sp.]]||'''S'''
 +
|}
 +
 +
===Key===
 +
{{Template:Antibacterial Spectra Key}}
  
 
==See Also==
 
==See Also==

Revision as of 03:54, 24 June 2014

General

  • Type:
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

Pediatric Dosing

Special Populations

  • Pregnancy:
  • Lactation:
  • Renal Dosing
    • Adult
    • Pediatric
  • Hepatic Dosing
    • Adult
    • Pediatric

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:
  • Mechanism of Action:

Antibiotic Sensitivities[1]

Group Organism Sensitivity
Gram Positive Strep. Group A, B, C, G S
Strep. Pneumoniae S
Viridans strep I
Strep. anginosus gp X1
Enterococcus faecalis R
Enterococcus faecium X1
MSSA I
MRSA R
CA-MRSA R
Staph. Epidermidis I
C. jeikeium R
L. monocytogenes R
Gram Negatives N. gonorrhoeae I
N. meningitidis I
Moraxella catarrhalis S
H. influenzae S
E. coli S
Klebsiella sp S
E. coli/Klebsiella ESBL+ R
E coli/Klebsiella KPC+ R
Enterobacter sp, AmpC neg S
Enterobacter sp, AmpC pos R
Serratia sp S
Serratia marcescens X1
Salmonella sp S
Shigella sp S
Proteus mirabilis S
Proteus vulgaris S
Providencia sp. S
Morganella sp. S
Citrobacter freundii R
Citrobacter diversus S
Citrobacter sp. S
Aeromonas sp S
Acinetobacter sp. I
Pseudomonas aeruginosa S
Burkholderia cepacia S
Stenotrophomonas maltophilia I
Yersinia enterocolitica I
Francisella tularensis X1
Brucella sp. X1
Legionella sp. R
Pasteurella multocida X1
Haemophilus ducreyi S
Vibrio vulnificus X1
Misc Chlamydophila sp X1
Mycoplasm pneumoniae X1
Rickettsia sp X1
Mycobacterium avium X1
Anaerobes Actinomyces X1
Bacteroides fragilis R
Prevotella melaninogenica S
Clostridium difficile X1
Clostridium (not difficile) S
Fusobacterium necrophorum X1
Peptostreptococcus sp. S

Key

  • S susceptible/sensitive (usually)
  • I intermediate (variably susceptible/resistant)
  • R resistant (or not effective clinically)
  • S+ synergistic with cell wall antibiotics
  • U sensitive for UTI only (non systemic infection)
  • X1 no data
  • X2 active in vitro, but not used clinically
  • X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
  • X4 active in vitro, but not clinically effective for strep pneumonia

See Also

Source

  1. Sanford Guide to Antimicrobial Therapy 2014